Patient Guide: Phase 3 LITESPARK-011: Welireg in combination with Lenvima for advanced renal cell carcinoma after anti-PD-1 therapy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at multiple participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTLITESPARK-011
Status: ANNOUNCED
Condition: Renal cell carcinoma, RCC
Phase: PHASE3

Loading interactive enrollment tools...

The full interactive experience will load momentarily